Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral lorazepam for preoperative dental anxiety in phobic patients (pilot)
2005-003749-15Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lorazepam in Dental anxiety and specific phobia, sponsored by Merck & Co. Started Oct 2005; status: terminated.
02
Drugs
lorazepam
03
Conditions
Dental anxietyspecific phobia
Beyond the preview
Go deeper on 2005-003749-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003749-15.